ReviewTherapeutic advances in drug safety2024

Abemaciclib pharmacology and interactions in the treatment of HR+/HER2- breast cancer: a critical review.

Federica Martorana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.